A Multi-centre Randomised Clinical Trial of Biomarker-driven Maintenance Treatment for First-line Metastatic Colorectal Cancer (MODUL)
Phase of Trial: Phase II
Latest Information Update: 28 Jun 2017
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary) ; Capecitabine (Primary) ; Vemurafenib (Primary) ; Cetuximab; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms MODUL
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 14 Feb 2017 This trial has been suspended in Netherlands as per European Clinical Trials Database record.
- 13 Jul 2016 This trial was suspended in Netherlands, according to European Clinical Trials Database.